Third Harmonic Bio
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Third Harmonic Bio generated cash of -$20,425,000, which is more than the previous year. Cash used in financing activities reached the amount of $799,000 last year. Net change in cash is therefore -$19,795,000.

Cash Flow

Third Harmonic Bio, Inc. (NASDAQ:THRD): Cash Flow
2020 -9.18M 0 10.82M
2021 -15.74M 0 135.74M
2022 -34.91M -36K 195.99M
2023 -20.42M -169K 799K

THRD Cash Flow Statement (2020 โ€“ 2023)

2023 2022 2021 2020
Cash at beginning of period
289.31M128.28M8.27M6.63M
Operating activities
Net income
-30.82M-35.15M-29.60M-12.80M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
35K1K00
Stock-based compensation expense
9.57M4.75M510K195K
Deferred income tax benefit 9.57M4.75M510K195K
Changes in operating assets and liabilities:
Accounts receivable, net
0000
Inventories
0000
Accounts payable
-249K290K1.21M324K
Cash generated by operating activities
-20.42M-34.91M-15.74M-9.18M
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-169K-36K00
Acquisitions Net
0000
Cash generated by investing activities
-169K-36K00
Financing activities
Common Stock Issued
799K198.17M135.74M10.82M
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
0000
Cash used in financing activities
799K195.99M135.74M10.82M
Net Change In Cash
-19.79M161.03M120.00M1.63M
Cash at end of period
269.52M289.31M128.28M8.27M
Data sourceData source